Latest news
New Combination Therapy Shows Promise for Advanced Bladder Cancer - CU Anschutz newsroomCU Anschutz newsroom · Thu, 06 Aug 2026 19:16:18 GMTHengrui Pharmaceuticals Gets China Nod for Lung Cancer Combo Trials - MoomooMoomoo · Wed, 05 Aug 2026 03:25:12 GMTCombination of targeted therapies could help overcome treatment resistance in advanced prostate cancer - Medical XpressMedical Xpress · Tue, 04 Aug 2026 17:00:10 GMTFDA Approves Lutetium Lu 177 Vipivotide Tetraxetan Plus ARPI for Prostate Cancer - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 10:27:38 GMTTalazoparib and Enzalutamide Combo Shows Promise in Treating Certain Prostate Cancers - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 00:00:00 GMTImfinzi Combo Cuts Risk of Death by 25% in Advanced Biliary Tract Cancer - Cure TodayCure Today · Fri, 31 Jul 2026 16:36:43 GMTNogapendekin Alfa Combo Earns UAE Marketing Authorization in NMIBC, NSCLC - CancerNetworkCancerNetwork · Thu, 30 Jul 2026 17:07:21 GMTHow 2 FDA citations complicate Hengrui, Elevar’s push for liver cancer combo approval - Fierce PharmaFierce Pharma · Tue, 28 Jul 2026 07:00:00 GMT